IOLYX Trademark

Trademark Overview

On Tuesday, February 8, 2022, a trademark application was filed for IOLYX with the United States Patent and Trademark Office. The USPTO has given the IOLYX trademark a serial number of 97258411. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, May 28, 2025. This trademark is owned by Hawkeye Therapeutics, Inc.. The IOLYX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals and pharmaceutical preparations all for use in the prevention and treatment of ophthalmological, immunological, and inflammatory diseases and disorders

Pharmaceutical research and development services; scientific and medical research services in the field of pharmaceutical development; scientific and medical information services in the field of pharmaceutical development, namely, providing information about medical and scientific research related to development of pharmaceuticals
iolyx

General Information

Serial Number97258411
Word MarkIOLYX
Filing DateTuesday, February 8, 2022
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, May 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceuticals and pharmaceutical preparations all for use in the prevention and treatment of ophthalmological, immunological, and inflammatory diseases and disorders
Goods and ServicesPharmaceutical research and development services; scientific and medical research services in the field of pharmaceutical development; scientific and medical information services in the field of pharmaceutical development, namely, providing information about medical and scientific research related to development of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 14, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIOLYX THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBurlingame, CA 94010
Party NameHawkeye Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94024

Trademark Events

Event DateEvent Description
Friday, February 11, 2022NEW APPLICATION ENTERED
Monday, February 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 19, 2022ASSIGNED TO EXAMINER
Friday, November 25, 2022NON-FINAL ACTION WRITTEN
Friday, November 25, 2022NON-FINAL ACTION E-MAILED
Friday, November 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, May 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 30, 2023SUSPENSION LETTER WRITTEN
Friday, June 30, 2023LETTER OF SUSPENSION E-MAILED
Friday, June 30, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 22, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 28, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 19, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 28, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, June 28, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 19, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, October 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, October 13, 2024ASSIGNED TO LIE
Thursday, November 7, 2024NON-FINAL ACTION E-MAILED
Thursday, November 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 7, 2024NON-FINAL ACTION WRITTEN
Monday, January 27, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, January 27, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, April 30, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 30, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 30, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 28, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, May 28, 2025FINAL REFUSAL WRITTEN
Wednesday, May 28, 2025FINAL REFUSAL E-MAILED
Wednesday, August 20, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, August 20, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Related Keywords

iolyx development pharmaceutical services medical scientific research information field pharmaceuticals namely